Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
19,603,857
-
Total 13F shares
-
396,422
-
Share change
-
+375,458
-
Total reported value
-
$713,974
-
Price per share
-
$1.80
-
Number of holders
-
8
-
Value change
-
+$617,439
-
Number of buys
-
6
-
Number of sells
-
3
Institutional Holders of Ensysce Biosciences, Inc. - Common Stock, par value $0.0001 per share (ENSC) as of Q2 2023
As of 30 Jun 2023 Ensysce Biosciences, Inc. - Common Stock, par value $0.0001 per share (ENSC) had 8 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 396,422 shares of stock of the company.
Largest 8 holders included SABBY MANAGEMENT, LLC, Anson Funds Management LP, GSA CAPITAL PARTNERS LLP, VANGUARD GROUP INC, Tower Research Capital LLC (TRC), BlackRock Inc., WOLVERINE ASSET MANAGEMENT LLC, and WELLS FARGO & COMPANY/MN.
This table shows 8 institutional shareholders of the security as of 30 Jun 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.